NM_003036.4:c.185C>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003036.4(SKI):​c.185C>G​(p.Ala62Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0703 in 1,396,788 control chromosomes in the GnomAD database, including 3,804 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A62S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.053 ( 290 hom., cov: 32)
Exomes 𝑓: 0.072 ( 3514 hom. )

Consequence

SKI
NM_003036.4 missense

Scores

1
1
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 1.59

Publications

14 publications found
Variant links:
Genes affected
SKI (HGNC:10896): (SKI proto-oncogene) This gene encodes the nuclear protooncogene protein homolog of avian sarcoma viral (v-ski) oncogene. It functions as a repressor of TGF-beta signaling, and may play a role in neural tube development and muscle differentiation. [provided by RefSeq, Oct 2009]
SKI Gene-Disease associations (from GenCC):
  • Shprintzen-Goldberg syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, PanelApp Australia, G2P, Genomics England PanelApp, ClinGen, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0017156601).
BP6
Variant 1-2228951-C-G is Benign according to our data. Variant chr1-2228951-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 139113.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0702 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SKINM_003036.4 linkc.185C>G p.Ala62Gly missense_variant Exon 1 of 7 ENST00000378536.5 NP_003027.1 P12755
SKIXM_005244775.4 linkc.185C>G p.Ala62Gly missense_variant Exon 1 of 7 XP_005244832.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SKIENST00000378536.5 linkc.185C>G p.Ala62Gly missense_variant Exon 1 of 7 1 NM_003036.4 ENSP00000367797.4 P12755
SKIENST00000704337.1 linkn.137+1427C>G intron_variant Intron 1 of 3

Frequencies

GnomAD3 genomes
AF:
0.0533
AC:
8011
AN:
150266
Hom.:
290
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0298
Gnomad AMI
AF:
0.0198
Gnomad AMR
AF:
0.0576
Gnomad ASJ
AF:
0.0949
Gnomad EAS
AF:
0.00605
Gnomad SAS
AF:
0.0760
Gnomad FIN
AF:
0.0318
Gnomad MID
AF:
0.151
Gnomad NFE
AF:
0.0693
Gnomad OTH
AF:
0.0687
GnomAD2 exomes
AF:
0.0877
AC:
4816
AN:
54924
AF XY:
0.0899
show subpopulations
Gnomad AFR exome
AF:
0.0347
Gnomad AMR exome
AF:
0.0680
Gnomad ASJ exome
AF:
0.107
Gnomad EAS exome
AF:
0.0124
Gnomad FIN exome
AF:
0.0415
Gnomad NFE exome
AF:
0.0920
Gnomad OTH exome
AF:
0.103
GnomAD4 exome
AF:
0.0724
AC:
90238
AN:
1246414
Hom.:
3514
Cov.:
32
AF XY:
0.0737
AC XY:
45257
AN XY:
614398
show subpopulations
African (AFR)
AF:
0.0281
AC:
690
AN:
24576
American (AMR)
AF:
0.0618
AC:
1059
AN:
17130
Ashkenazi Jewish (ASJ)
AF:
0.101
AC:
2009
AN:
19902
East Asian (EAS)
AF:
0.00432
AC:
113
AN:
26160
South Asian (SAS)
AF:
0.0915
AC:
5762
AN:
62994
European-Finnish (FIN)
AF:
0.0414
AC:
1299
AN:
31392
Middle Eastern (MID)
AF:
0.123
AC:
476
AN:
3862
European-Non Finnish (NFE)
AF:
0.0744
AC:
75165
AN:
1010124
Other (OTH)
AF:
0.0729
AC:
3665
AN:
50274
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
4150
8300
12450
16600
20750
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2908
5816
8724
11632
14540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0533
AC:
8009
AN:
150374
Hom.:
290
Cov.:
32
AF XY:
0.0510
AC XY:
3746
AN XY:
73436
show subpopulations
African (AFR)
AF:
0.0297
AC:
1228
AN:
41338
American (AMR)
AF:
0.0574
AC:
869
AN:
15132
Ashkenazi Jewish (ASJ)
AF:
0.0949
AC:
326
AN:
3436
East Asian (EAS)
AF:
0.00607
AC:
31
AN:
5110
South Asian (SAS)
AF:
0.0767
AC:
370
AN:
4826
European-Finnish (FIN)
AF:
0.0318
AC:
316
AN:
9922
Middle Eastern (MID)
AF:
0.152
AC:
44
AN:
290
European-Non Finnish (NFE)
AF:
0.0693
AC:
4665
AN:
67320
Other (OTH)
AF:
0.0679
AC:
142
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
378
755
1133
1510
1888
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
100
200
300
400
500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0583
Hom.:
39
Bravo
AF:
0.0544
TwinsUK
AF:
0.0752
AC:
279
ALSPAC
AF:
0.0706
AC:
272
ExAC
AF:
0.0314
AC:
1578
Asia WGS
AF:
0.0290
AC:
100
AN:
3426

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 16, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 24, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Ala62Gly in exon 1 of SKI: This variant is not expected to have clinical signifi cance because it has been identified in 10.6% (14/132) of Mexican chromosomes fr om a broad population by the 1000 Genomes Project (http://www.ncbi.nlm.nih.gov/p rojects/SNP; dbSNP rs28384811). -

Apr 04, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Shprintzen-Goldberg syndrome Benign:3
Nov 27, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Familial thoracic aortic aneurysm and aortic dissection Benign:1
Dec 30, 2014
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.088
BayesDel_addAF
Benign
-0.31
T
BayesDel_noAF
Benign
-0.14
CADD
Benign
20
DANN
Benign
0.97
DEOGEN2
Benign
0.21
T
Eigen
Benign
-0.037
Eigen_PC
Benign
-0.050
FATHMM_MKL
Benign
0.73
D
LIST_S2
Benign
0.60
T
MetaRNN
Benign
0.0017
T
MetaSVM
Benign
-0.30
T
MutationAssessor
Benign
0.0
N
PhyloP100
1.6
PrimateAI
Pathogenic
0.87
D
PROVEAN
Benign
-0.14
N
REVEL
Benign
0.20
Sift
Uncertain
0.017
D
Sift4G
Benign
0.47
T
Polyphen
0.98
D
Vest4
0.10
MPC
1.6
ClinPred
0.021
T
GERP RS
2.3
Varity_R
0.074
gMVP
0.39
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28384811; hg19: chr1-2160390; COSMIC: COSV66013939; COSMIC: COSV66013939; API